Hydroxymethylfurfural
Small moleculeexperimental
Clinical trial activity
3 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2012 (NCT01597401)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 5-hm-2-f cpd
- 5-hmf cpd
- 5-(hydroxymethyl)-2-furaldehyde
- 5-(hydroxymethyl)-2-furaldehyde
- 5-hydroxymethyl-2-furaldehyde
- 5-hydroxymethyl-2-furfural
- 5-hydroxymethylfuraldehyde
- 5-hydroxymethylfurfural
- 5-(hydroxymethyl)furfural
- 5-hydroxymethyl furfural
- 5-hydroxymethylfurfuraldehyde
- aes-103
- aes-103
- aes-103
- hydroxymethylfurfural
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01987908 | Phase 2 | Oct 1, 2013 | Baxalta |
| NCT01871142 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2013 | AesRx, Colorado State University |
| NCT01597401 | Phase 1 | May 1, 2012 | Baxalta, Cato Research, National Cheng Kung University, National Heart, Lung, and Blood Institute (NHLBI), Nuventra Pharma Sciences, Inc., Quotient, Ricerca Biosciences LLC, SAIC-Frederick, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baxalta | For profit | 2 | 2 | 2 | 2012 |
| AesRx | For profit | 1 | 0 | 1 | 2013 |
| Cato Research | For profit | 1 | 0 | 1 | 2012 |
| Colorado State University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| National Cheng Kung University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2012 |
| Nuventra Pharma Sciences, Inc. | For profit | 1 | 0 | 1 | 2012 |
| Quotient | For profit | 1 | 0 | 1 | 2012 |
| Ricerca Biosciences LLC | For profit | 1 | 0 | 1 | 2012 |
| SAIC-Frederick, Inc. | For profit | 1 | 0 | 1 | 2012 |
10 organizations
Page 1 / 1